The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final result for SAFIA trial for neoadjuvant palbociclib in patients with operable luminal breast cancer responding to fulvestrant.
 
Khalid A. Al-Saleh
Honoraria - Amgen; AstraZeneca; Novartis; Pfizer; Roche
Research Funding - AstraZeneca; Pfizer
 
Heba Mohamed El Zawahry
No Relationships to Disclose
 
Adda Bounedjar
No Relationships to Disclose
 
Mohammed Oukkal
Consulting or Advisory Role - Amgen; Ipsen; Ipsen; Ipsen; Novartis; Roche
Speakers' Bureau - Bayer; Ipsen
 
Ahmed Saadeddin
No Relationships to Disclose
 
Hassen Mahfouf
No Relationships to Disclose
 
Bouzid Kamel
Consulting or Advisory Role - Merck; MSD Oncology; MYLAN; Pfizer; ROCHE; ROCHE; Sanofi
 
Assia Bensalem
No Relationships to Disclose
 
Hikmat Abdel-Razeq
No Relationships to Disclose
 
Alaa Kandil
No Relationships to Disclose
 
Omalkhair A. M. Abulkhair
Consulting or Advisory Role - Lilly; Pfizer; Roche
 
Meteb Owaish Al-Foheidi
Honoraria - Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - Novartis
Speakers' Bureau - AstraZeneca; Lilly; Lilly; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Pfizer; Roche
 
Marwan Ghosn
No Relationships to Disclose
 
Hamouda Boussen
No Relationships to Disclose
 
Abderrazak Haddaoui
No Relationships to Disclose
 
Jihene Braham Ayari
No Relationships to Disclose
 
Mohammed Alghamdi
No Relationships to Disclose
 
Nashwa A. Abdulaziz
No Relationships to Disclose
 
Sharif Ahmed Kullab
Travel, Accommodations, Expenses - Pfizer
 
Jean-Marc A. Nabholtz
Honoraria - Amgen; AstraZeneca; MSD; Novartis; Pfizer
Research Funding - AstraZeneca; Genomic Health; Pfizer